4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-006910
Options or other derivatives
- Executive Chairman acquired 525,000 shares (grant or award)
From the SEC's structured data for this filing
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-006910
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…